Abstract |
Asthma is a common condition that can substantially affect patients' quality of life. Although several drugs, most commonly beta-adrenergic agonists, alleviate symptoms of asthma, they may cause paradoxical bronchospasm or paradoxical bronchoconstriction. Levalbuterol hydrochloride-a pure form of the (R)-stereoisomer in racemic albuterol-eliminates the adrenergic properties that can cause such adverse effects. However, we report a case of paradoxical bronchoconstriction in a 36-year-old man who was recently diagnosed as having new-onset asthma and was treated with levalbuterol.
|
Authors | Sarah E Broski, Dennis E Amundson |
Journal | The Journal of the American Osteopathic Association
(J Am Osteopath Assoc)
Vol. 108
Issue 4
Pg. 211-3
(Apr 2008)
ISSN: 1945-1997 [Electronic] United States |
PMID | 18443029
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Adrenergic beta-Agonists
- Albuterol
|
Topics |
- Adrenergic beta-Agonists
(administration & dosage, adverse effects)
- Adult
- Albuterol
(administration & dosage, adverse effects)
- Asthma
(drug therapy)
- Bronchial Diseases
(chemically induced)
- Constriction, Pathologic
(chemically induced)
- Humans
- Male
- Metered Dose Inhalers
|